In the News

Photo of real female scientists researching in laboratory.

Emerging Use of Bacteriophages, Natural Predators of Bacteria, to Combat Antibiotic Resistance in the Clinic and Beyond: A Review of the Field and Biosafety Assessment

Explore the latest research on bacteriophage therapy, including advances in clinical development, biosafety, and regulation.

Clinical research professionals talking and gesturing to a laptop

In the News

Guidelines needed for the use of AI in the preparation or review of IRB, IBC,and IACUC applications

Daniel Eisenmanc, James Riddlec, and Stephanie Pyle from Advarra all co-authored the published article, “Guidelines…

Cell & Gene Therapy Review Beyond the Breakthrough article cover

In the News

Beyond the Breakthrough: Navigating the realities of CAR-T cell oncology trials

Beyond the Breakthrough explores the challenges of CAR-T oncology trials, from complex logistics and safety…

In the News

Navigating AI in Clinical Trials: Insights from Advarra’s Laura Russell

Advarra has launched the Council for Responsible AI in Clinical Trials to ensure the ethical…

In the News

Clinical Trials Get A Council For AI Oversight

You can’t throw a rock in clinical research right now without hitting someone pitching some…

In the News

Gene Therapy Successes in Ophthalmology

Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients,…

In the News

The Latest Advancements in Single Sign-On Technology

Stuart Cotter dives in how today’s single sign-on reduces site burden and spearheads clinical system…

In the News

The “One-and-Done” PI & Measuring the Current Site Landscape

Advarra’s Elisa Cascade joins other industry leaders, SCRS’ Jimmy Bechtel, Advarra’s Elisa Cascade, Tufts Center…

In the News

Clinical Research Trends to Expect in 2025: More Complex, Less Connected

Christine Senn digs into the results of Advarra’s Site-Sponsor-CRO Collaboration survey to reveal some new…

In the News

A balancing act: Innovating IRBs for the future of pediatric oncology research

Advarra deep-dives into special considerations needed for high-quality and sensitive pediatric oncology trial IRB reviews.

In the News

The Broken Site Feasibility Process – Could CROs Be the Fixers?

Advarra’s Christine Senn discusses compelling data from a recent site feasibility survey, the opportunity for…

In the News

Why Data Monitoring Committees are Crucial in Multi-Regional Oncology Trials

Check out this informative read about the importance of Data Monitoring Committees in multi-site oncology…

In the News

Research Sites Need a Lifeline

Elisa Cascade drills down on the challenges that sites have with technology and key ways…

In the News

When Clinical Trials Suffer From ‘Complicated’ Interactions

Learn more about the 2024 Advarra Site-Sponsor/CRO Collaboration Survey results and how we can help…

In the News

The Path Ahead to Improve DEI in Clinical Trials

Check out this insightful article about how the industry will make progress with diversity, equity,…

In the News

Fear Replaced by Understanding, Optimism, and Miracles: Part I

The Medicine Maker featured Advarra’s Daniel Eisenman’s in-depth reflection on how things are evolving in…

In the News

The EU AI Regulation: Transforming Clinical Research Through Regulation

In this rich article, Advarra’s James Riddle discusses the possibilities for AI in clinical research,…

In the News

New Predictions for 2025

Advarra executives discuss what the anticipate happening in the industry for 2025.

In the News

Opinion: A Cautiously Sunny Outlook for Biopharma in 2025

Read a preview of how the financial climate in the pharmaceutical industry will ebb and…

In the News

The Clinical Trials of 2025

Elisa Cascade highlights her predictions for what is coming in 2025 in the world of…

In the News

Technology At Clinical Sites: The Good, The Bad, And What Sponsors Can Do To Turn It Around

A new feature article in Global Forum highlights data from Advarra’s 2024 Site/Sponsor/CRO Collaboration survey…

In the News

Using Artificial Intelligence to Manage Clinical Trial Conduct

Learn what’s in store for AI in clinical research with Advarra’s Chief Technology Officer.

BioSpectrum Asia Edition featured news slide

In the News

2025 Trends Buoying Boom Phase in APAC

This staff-written feature article discusses the predictions for 2025 from industry leaders, including Advarra’s Jeff…

In the News

Breaking Bottlenecks in Clinical Trials

Experts discuss what to expect in drug development in 2025, including ways to break the…

In the News

Communication, Staffing, Technology: The Persistent Barriers in Clinical Trials

In this article, Biopharma Trend does a deep-dive into Advarra’s 2024 Site/Sponsor/CRO Collaboration survey results,…

In the News

Trial Sites and Sponsors Continue to Face Same Challenges of Silos, Inadequate Sponsor Communications, Staff Shortages: Survey

Trial Site News offers a new spin on Advarra’s 2024 Site-Sponsor/CRO Collaboration Survey report —…

In the News

Want to see the latest news and updates about Advarra? You can find them in the Newsroom

In the News

Emerging Use of Bacteriophages, Natural Predators of Bacteria, to Combat Antibiotic Resistance in the Clinic and Beyond: A Review of the Field and Biosafety Assessment

Guidelines needed for the use of AI in the preparation or review of IRB, IBC,and IACUC applications

Beyond the Breakthrough: Navigating the realities of CAR-T cell oncology trials

Navigating AI in Clinical Trials: Insights from Advarra’s Laura Russell

Clinical Trials Get A Council For AI Oversight

Gene Therapy Successes in Ophthalmology

The Latest Advancements in Single Sign-On Technology

The “One-and-Done” PI & Measuring the Current Site Landscape

Clinical Research Trends to Expect in 2025: More Complex, Less Connected

A balancing act: Innovating IRBs for the future of pediatric oncology research

The Broken Site Feasibility Process – Could CROs Be the Fixers?

Why Data Monitoring Committees are Crucial in Multi-Regional Oncology Trials

Research Sites Need a Lifeline

When Clinical Trials Suffer From ‘Complicated’ Interactions

The Path Ahead to Improve DEI in Clinical Trials

Fear Replaced by Understanding, Optimism, and Miracles: Part I

The EU AI Regulation: Transforming Clinical Research Through Regulation

New Predictions for 2025

Opinion: A Cautiously Sunny Outlook for Biopharma in 2025

The Clinical Trials of 2025

Technology At Clinical Sites: The Good, The Bad, And What Sponsors Can Do To Turn It Around

Using Artificial Intelligence to Manage Clinical Trial Conduct

2025 Trends Buoying Boom Phase in APAC

Breaking Bottlenecks in Clinical Trials

Communication, Staffing, Technology: The Persistent Barriers in Clinical Trials

Trial Sites and Sponsors Continue to Face Same Challenges of Silos, Inadequate Sponsor Communications, Staff Shortages: Survey

Advarra Publishes Latest Site-Sponsor-CRO Collaboration Survey Results

AMR Deploys Advarra’s Site Training and Engagement Platform

From Isolation to Integration: Improving Site-Sponsor Collaboration in Clinical Trial Startup

IVF Restrictions, Demise of Roe v. Wade Could Endanger Women’s Health Research

Looking for More?

Are You Ready to Bring People Together for Better, Faster Trial Outcomes?